Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

SSE:603392.SS

64.14 (CNY) • At close June 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 400.625297.292582.066604.961749.565533.798805.2541,277.0392,886.6022,534.6682,720.7932,758.5043,171.2232,154.3411,632.0141,139.95824.024755.014755.527532.816310.899353.449306.671273.094250.54265.312265.312226.031226.031
Cost of Revenue 134.003210.22182.306217.726202.777257.028185.601163.773242.259268.561261.485313.812326.553318.218209.148161.691128.653126.836135.64391.37788.28592.10386.48675.6476.63574.2874.2867.57367.573
Gross Profit 266.62287.072399.76387.235546.788276.77619.6531,113.2672,644.3432,266.1072,459.3082,444.6922,844.671,836.1231,422.865978.259695.371628.178619.884441.439222.614261.346220.184197.454173.905191.033191.033158.458158.458
Gross Profit Ratio 0.6660.2930.6870.640.7290.5180.770.8720.9160.8940.9040.8860.8970.8520.8720.8580.8440.8320.820.8290.7160.7390.7180.7230.6940.720.720.7010.701
Reseach & Development Expenses 138.625159.838246.283245.093206.735385.255349.245245.587217.843719.328146.396126.996106.31228.435248.963126.13378.292121.65662.36185.49744.81852.41542.99440.62629.94535.98835.98833.18133.181
General & Administrative Expenses 92.913-170.417202.127-39.38374.995-152.927179.84-41.78258.576-107.614133.093-31.58548.685-87.622107.777-16.48333.851-58.38930.679-24.89635.325-103.82747.03843.10937.16443.66143.66133.30433.304
Selling & Marketing Expenses 103.473-53.544166.199111.475203.52283.915232.639370.891907.65739.048880.499658.625975.776608.438522.863321.258237.914242.273238.447136.73473.49105.5282.9880.53564.35769.69669.69663.17563.175
SG&A 196.386-223.961205.393162.143313.539165.103412.479329.11966.225631.4341,013.592627.0411,024.461520.815630.64304.775271.765183.884269.126111.838108.8161.693130.018123.644101.521113.289113.28997.15197.151
Other Expenses -12.593321.831-206.744-7.898-9.156-404.156-0.751-1.23-21.7780.386-121.01265.515-5.252-4.1590.054-0.168-0.037-0.101-3.879-7.661.24-0.961-0.183-0.348-0.030000
Operating Expenses 322.418257.707407.865415.135529.431954.514647.209672.2061,162.2981,431.1481,038.975819.5521,125.52854.434819.577475.95346.279385.268325.264234.218141.629186.587166.6149.924128.486108.483108.48397.01397.013
Operating Income -55.796-170.635-48.198-27.917.358-677.74568.858502.4521,433.597887.0771,451.6961,625.5331,631.732962.394544.027485.265336.77213.474276.234204.83780.65872.35953.347.51245.15939.83939.83926.72126.721
Operating Income Ratio -0.139-0.574-0.083-0.0460.023-1.270.0860.3930.4970.350.5340.5890.5150.4470.3330.4260.4090.2830.3660.3840.2590.2050.1740.1740.180.150.150.1180.118
Total Other Income Expenses Net -2.104-8.03636.202-12.148-2.28168.373-0.751-1.23-0.164-10.432-1.358-0.991-0.566-4.1590.054-0.168-0.037-0.452-3.879-7.661.24-0.961-0.183-0.348-0.030.4920.4920.0890.089
Income Before Tax -57.9-178.671-11.996132.509125.64-609.37268.107501.2231,433.433876.6451,450.3381,624.5431,631.166958.236544.081485.097336.733213.022272.355197.17681.89871.39853.11747.16445.12984.584.560.64460.644
Income Before Tax Ratio -0.145-0.601-0.0210.2190.168-1.1420.0850.3920.4970.3460.5330.5890.5140.4450.3330.4260.4090.2820.360.370.2630.2020.1730.1730.180.3180.3180.2680.268
Income Tax Expense -3.758-17.28-18.886-1.304-4.144-44.11-34.32944.636180.69152.652190.262232.077244.39892.65458.51847.21546.5441.72649.15120.63611.124-13.62513.4721.3135.3467.0837.0835.7895.789
Net Income -52.777-160.4146.169134.772125.708-560.684106.006457.441,244.918791.9891,250.8651,362.0361,330.905833.267466.692432.292289.216210.293222.884173.38470.43783.8240.00944.78940.24691.98591.98554.54954.549
Net Income Ratio -0.132-0.540.0110.2230.168-1.050.1320.3580.4310.3120.460.4940.420.3870.2860.3790.3510.2790.2950.3250.2270.2370.130.1640.1610.3470.3470.2410.241
EPS -0.04-0.120.0050.110.1-0.450.0850.360.990.630.981.111.080.680.380.350.240.180.170.140.0630.0790.0360.0430.0350.090.090.0490.049
EPS Diluted -0.04-0.120.0050.110.1-0.450.0850.360.990.630.981.111.080.680.380.350.240.180.170.140.0630.0790.0350.0430.0350.090.090.0490.049
EBITDA -55.874-174.715-10.836204.585127.367-599.773148.067617.9851,550.327925.1461,451.3511,659.4371,666.355990.857575.499511.687362.099235.213290.09217.105101.42771.65665.61266.08165.65552.99146.56133.61633.616
EBITDA Ratio -0.139-0.588-0.0190.3380.17-1.1240.1840.4840.5370.3650.5330.6020.5250.460.3530.4490.4390.3120.3840.4070.3260.2030.2140.2420.2620.20.1750.1490.149